BlackRock Science and Technology Trust Rights (expiring July 14, 2021)
BST.RT
BST.RT was delisted on the 13th of July, 2021.
0 hedge funds and large institutions have $0 invested in BlackRock Science and Technology Trust Rights (expiring July 14, 2021) in 2021 Q3 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 50 closing their positions.
100% less funds holding
Funds holding: 52 → 0 (-52)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
100% less capital invested
Capital invested by funds: $5.33M → $0 (-$5.33M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 50
Top Buyers
Top Sellers
BST.RT Hedge Fund Activity: Q3 2021 in Review
0 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in BlackRock Science and Technology Trust Rights (expiring July 14, 2021) (BST.RT) for Q3 2021, worth a combined $0 — down 100% from $5.33M a quarter earlier.
Sellers outnumbered buyers: 50 funds closed out of BST.RT and 0 opened new positions — a net loss of 50 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was UBS Group, exiting entirely with an estimated $2.31M sold.
- 0 institutional investors held BlackRock Science and Technology Trust Rights (expiring July 14, 2021) (BST.RT) as of Q3 2021, down from 52 in Q2 2021.
- Funds reported $0 of BlackRock Science and Technology Trust Rights (expiring July 14, 2021) stock for Q3 2021, down 100% quarter-over-quarter.
- 0 funds opened new BlackRock Science and Technology Trust Rights (expiring July 14, 2021) positions in Q3 2021 and 50 closed out, a net change of -50 holders.
- The largest BlackRock Science and Technology Trust Rights (expiring July 14, 2021) seller in Q3 2021 was UBS Group, an estimated $2.31M sold.
Based on aggregated 13F filings for Q3 2021.